LEADERSHIP

We are led by a team with deep, relevant experience for developing novel therapeutics that address large unmet needs for people with neurological disorders.

Joe Blanchard, MBA

Board Director & Advisor

Michel Baudry, PhD

Chief Scientific Advisor
.

Francesco Salituro, PhD

Preclinical Drug Development

Shujaath Mehdi, PhD

Biochemical Pharmacology

Philippe Bey, PhD

Chemistry

Kathy Fosnaugh, PhD

Program Management

Scientific & clinical Advisors

 Ramon Diaz-Arrastia, MD, PhD

 Presidential Professor of Neurology and Director of Clinical Traumatic Brain Injury (TBI) Research
University of Pennsylvania Perelman School of Medicine

Imad Najm, MD

 Director, Epilepsy Center

Cleveland Clinic
.

Barry Jordan, MD, MPH

Chief Medical Officer

Rancho Los Amigos National Rehabilitation Center

Michael Palfreyman, PhD

Palfreyman BioPharm Advisors, LLC